Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPT | P10636 | 7/20 | 0.41 |
| ▸ | MEN1 | O00255 | 6/20 | 0.41 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 5/20 | 0.41 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.41 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.41 |
| ▸ | LMNA | P02545 | 1/20 | 0.41 |
| ▸ | POLB | P06746 | 1/20 | 0.41 |
| ▸ | RECQL | P46063 | 1/20 | 0.41 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.41 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.39 |
| ▸ | HSD17B10 | Q99714 | 3/20 | 0.39 |
| ▸ | HPGD | P15428 | 3/20 | 0.39 |
| ▸ | CACNA1B | Q00975 | 1/20 | 0.39 |
| ▸ | APBA1 | Q02410 | 1/20 | 0.39 |
| ▸ | NPSR1 | Q6W5P4 | 2/20 | 0.38 |
| ▸ | PLA2G1B | P04054 | 1/20 | 0.38 |
| ▸ | BLM | P54132 | 1/20 | 0.38 |
| ▸ | ATG4B | Q9Y4P1 | 1/20 | 0.38 |
| ▸ | NPC1 | O15118 | 6/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL21481189 | 0.91 | NPC1 (0.42) | MAPTMEN1KMT2AKDM4ETDP1 | |
| SCHEMBL28772850 | 0.79 | NPC1 (0.46) | MAPTMEN1KMT2AKDM4ETDP1 | |
| SCHEMBL28879176 | 0.77 | ALDH1A1 (0.49) | MAPTMEN1KMT2AKDM4ETDP1 | |
| SCHEMBL29693328 | 0.72 | GP6 (0.47) | MAPTMEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL16922525 | 0.72 | GP6 (0.47) | MAPTMEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL18134292 | 0.72 | GP6 (0.47) | MAPTMEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL21881794 | 0.72 | L3MBTL1 (0.48) | MAPTMEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL19512863 | 0.72 | GP6 (0.47) | MAPTMEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL18134290 | 0.72 | GP6 (0.47) | MAPTMEN1KMT2AKDM4EL3MBTL1 | |
| SCHEMBL28467605 | 0.71 | RAB9A (0.47) | MAPTMEN1KMT2AKDM4ETDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230250112-A1 | ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD | Zhejiang Brilliant Optoelectronic Technology Co.,Ltd. (CN) | 2023-08-10 | — | — | US | disclosed |
| US-11239428-B2 | Boron-containing organic compound and applications thereof, organic mixture, and organic electronic device | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2022-02-01 | — | — | US | disclosed |
| US-20200066997-A1 | ORGANIC COMPOUND CONTAINING BORON AND USES THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE | GUANGZHOU CHINARAY OPTOELECTRONIC MATERIALS LTD. (CN) | 2020-02-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230250112-A1 | ORGANIC COMPOUNDS AND APPLICATIONS THEREOF IN OPTOELECTRONIC FIELD | AOX1, AOC2, OR10J3 | MAPT 1093/4885MEN1 1783/4885KMT2A 4013/4885 |
| US-20200066997-A1 | ORGANIC COMPOUND CONTAINING BORON AND USES THEREOF, ORGANIC MIXTURE, AND ORGANIC ELECTRONIC DEVICE | OR10J3, OSTC, BCL6B | MAPT 1279/4885MEN1 552/4885KMT2A 2329/4885 |
| US-11239428-B2 | Boron-containing organic compound and applications thereof, organic mixture, and organic electronic device | BCL6B, BCL6, BTD | MAPT 1188/4885MEN1 630/4885KMT2A 2404/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.